Clinical Trial Update: Evaluation of Efficacy and Safety De-escalation Versus Standard Adjuvant Chemotherapy in Patients With Low Risk Localized Gastroesophageal Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating de-escalation versus standard adjuvant chemotherapy in patients with low-risk localized gastroesophageal cancer; the study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer
• Gastroesophageal Junction Cancer

Snippet

Sponsor: Centre Leon Berard | Conditions: Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma, Non Metastatic Disease | Phase 2 | Status: NOT_YET_RECRUITING